See the latest news and media coverage for Manas. We track all announcements, press releases, and industry mentions in real time, all in one place.
AI-native biopharmaceutical company
manasai.coLast updated
In short: Manas launched as an AI-powered drug discovery startup and secured over $50 million in total seed funding to transform cancer research.
The deal grants deep access to Schrödinger’s physics-based platform, expert support, and integration to enhance AI-driven drug discovery. CEO Siddhartha Mukherjee highlights competitive advantage.
The company raised funds to accelerate foundational models, advance therapeutic campaigns, and expand its interdisciplinary team, welcoming Ujjwal Singh as co-founder and CTO.
Jonathan Baell brings over 20 years of medicinal chemistry experience to lead scientific strategy and research at Manas AI.
Manas AI aims to accelerate drug development using AI and human expertise, backed by $24.6 million in seed funding and partnerships with Microsoft and investors.
According to its website, Manas AI describes itself as an,"AI-native biopharmaceutical company combining pioneering AI technology with the first principles of chemistry, physics, and biology...
AI Cancer Research Startup Manas AI - is connected to market cycles, sector performance, and capital rotation across global financial markets. LinkedIn co-founder Reid Hoffman...
Investment Advice Group - Assess leadership quality with comprehensive analysis. LinkedIn co-founder Reid Hoffman and renowned oncologist Siddhartha Mukherjee have secured $24.6 million to launch...
Catch the trend, capture the profit. Momentum indicators and trend analysis strategies to ride the strongest directional moves in the market. Identify stocks with the...
Track Manas and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Manas and other trending companies.